galafold
amicus therapeutics europe limited - migalastat hydrochloride - fabry disease - migalastat - galafold is indicated for long-term treatment of adults and adolescents aged 16 years and older with a confirmed diagnosis of fabry disease (α-galactosidase a deficiency) and who have an amenable mutation.
lipertance tablets film-coated
les laboratoires servier industrie 905 - atorvastatin (atorvastatin calcium trihydrate), perindopril arginine, amlodipine (amlodipine besilate) - tablets film-coated - 20mg+ 10mg+ 5mg
azitrox powder for oral suspension
pharmstandard-leksredstva jsc - azithromycin (azithromycin dihydrate) - powder for oral suspension - 200mg/5ml
betasalic ointment
kievmedpreparat pjsc - betamethasone (betamethasone dipropionate), salicylic acid - ointment - 0,64mg/g+ 30mg/g
levicitam tablets film-coated
pharma start llc - levetiracetam - tablets film-coated - 500mg (30/3x10/) in blister, (60/6x10/) in blister
pombiliti
amicus therapeutics europe limited - cipaglucosidase alfa - glycogen storage disease type ii - other alimentary tract and metabolism products, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).
opfolda
amicus therapeutics europe limited - miglustat - glycogen storage disease type ii - other alimentary tract and metabolism products - opfolda (miglustat) is an enzyme stabiliser of cipaglucosidase alfa long-term enzyme replacement therapy in adults with late-onset pompe disease (acid α- glucosidase [gaa] deficiency).
cpg 312 gel breast implant cohesive iii, low height, moderate plus profile